Partnership Overview

The following is placeholder text known as “lorem ipsum,” which is scrambled Latin used by designers to mimic real copy. Mauris egestas at nibh nec finibus. Donec eget risus diam. In sit amet felis malesuada, feugiat purus eget, varius mi.

Out-Licensing

Out-Licensing of our Opioid Abuse-Deterrent products & ADHD Overdose Program.

Life Cycle Management

As proprietary schedule 3 & 4 drugs look to extend their patent and market positioning, abuse deterrent & overdose management are variables that can now be addressed while delivering a Prodrug solution. The benefit of a novel Prodrug NCE (new chemical entity) solution are the obtainable patent real estate in otherwise commoditized markets, lending to an extended proprietary market position.

Specialized Abuse Deterrent or Overdose Uses

As new drugs come to market that are shown to have addictive and/or abusive profiles, our technology can be applied to address those concerns while expanding a firm's product pipeline. The potential application of THC (Tetrahydrocannabinol) is a good example of a category of drugs that could benefit from BIOMD and MPAR.